Upregulation of FHL1, SPNS3, and MPZL2 predicts poor prognosis in pediatric acute myeloid leukemia patients with FLT3-ITD mutation

References

• de Rooij JD, Michel Zwaan C, van den Heuvel-Eibrink M, et al. Pediatric AML: from biology to clinical management. J Clin Med. 2015;4:127–149.
   PubMed Web of Science ®Google Scholar
• Szalontay L, Shad AT. Pediatric acute myeloid leukemia: how to improve outcome? Curr Pediatr Rep. 2014;2(1):26–37.
   Google Scholar
• Chaudhury S, O’Connor C, Cañete A, et al. Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias. Nat Commun. 2018;9(1):14.
   PubMedGoogle Scholar
• Saultz J, Garzon R. Acute myeloid leukemia: a concise review. J Clin Med. 2016;5(3):33.
   PubMed Web of Science ®Google Scholar
• Siveen KS, Uddin S, Mohammad RM. Targeting acute myeloid leukemia stem cell signaling by natural products. Mol Cancer. 2017;16(1):12.
   PubMedGoogle Scholar
• Torrebadell M, Díaz-Beyá M, Kalko SG, et al. A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia. Leuk Lymphoma. 2018;59(10):2394–2404.
   PubMed Web of Science ®Google Scholar
• Meshinchi S, Alonzo TA, Stirewalt DL, et al. Clinical implications of FLT3 mutations in pediatric AML. Blood. 2006;108(12):3654–3661.
   PubMed Web of Science ®Google Scholar
• Fröhling S, Schlenk RF, Stolze I, et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol. 2004;22(4):624–633.
   PubMed Web of Science ®Google Scholar
• Hollink I, Zwaan CM, Zimmermann M, et al. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia. 2009;23(2):262–270.
   PubMed Web of Science ®Google Scholar
• Law CW, Alhamdoosh M, Su S, et al. RNA-seq analysis is easy as 1-2-3 with limma, glimma and edgeR. F1000Res. 2016;5:1408.
   Google Scholar
• Gerstung M, Pellagatti A, Malcovati L, et al. Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nat Commun. 2015;6(1):11.
   Google Scholar
• Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
   PubMed Web of Science ®Google Scholar
• Handschuh L, Lonetti A. Not only mutations matter: molecular picture of acute myeloid leukemia emerging from transcriptome studies. J Oncol. 2019;2019:1–36.
   Web of Science ®Google Scholar
• Verhaak RGW, Wouters BJ, Erpelinck CAJ, et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica. 2009;94(1):131–134.
   PubMed Web of Science ®Google Scholar
• Goldman M, Craft B, Hastie M, et al. The UCSC Xena platform for public and private cancer genomics data visualization and interpretation. bioRxiv. 2018;326470.
   Google Scholar
• Stölzel F, Mohr B, Kramer M, et al. Karyotype complexity and prognosis in acute myeloid leukemia. Blood Cancer J. 2016;6:386.
   PubMed Web of Science ®Google Scholar
• Huang Y, Hu J, Lu T, et al. Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis. Cancer Manag Res. 2019;11:4129–4142.
   PubMed Web of Science ®Google Scholar
• Wang T, Wang Z, Wang B. Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia; 2021.
   Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
   PubMed Web of Science ®Google Scholar
• Pedregosa F, Michel V, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. 2011;12:2825–2830.
   Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
   PubMed Web of Science ®Google Scholar
• Simon N, Friedman J, Hastie T, et al. Regularization paths for Cox’s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1–13.
   PubMed Web of Science ®Google Scholar
• Tibshirani R, Bien J, Friedman J, et al. Strong rules for discarding predictors in lasso-type problems. J R Stat Soc Series B Stat Methodol. 2012;74(2):245–266.
   PubMed Web of Science ®Google Scholar
• Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313(18):1111–1116.
   PubMed Web of Science ®Google Scholar
• Lee KY, Shueng PW, Chou CM, et al. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling. Cancer Sci. 2020;111(5):1652–1662.
   PubMed Web of Science ®Google Scholar
• Zhou J, Bi C, Chng W-J, et al. PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapy. PLOS One. 2011;6(5):e19798.
   PubMed Web of Science ®Google Scholar
• Stein U, Walther W, Arlt F, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15(1):59–67.
   PubMed Web of Science ®Google Scholar
• Liao JM, Cao B, Deng J, et al. TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene. Sci Rep. 2016;6:23542.
   PubMed Web of Science ®Google Scholar
• Kazim N, Adhikari A, Oh TJ, et al. The transcription elongation factor TCEA3 induces apoptosis in rhabdomyosarcoma. Cell Death Dis. 2020;11(1):11.
   PubMed Web of Science ®Google Scholar
• Li J, Jin Y, Pan S, et al. TCEA3 attenuates gastric cancer growth by apoptosis induction. Med Sci Monit. 2015;21:3241–3246.
   PubMed Web of Science ®Google Scholar
• Cha Y, Kim DK, Hyun J, et al. TCEA3 binds to TGF-beta receptor I and induces smad-independent, JNK-dependent apoptosis in ovarian cancer cells. Cell Signal. 2013;25(5):1245–1251.
   PubMed Web of Science ®Google Scholar
• Baghy K, Reszegi A, Tátrai P, et al. Decorin in the tumor microenvironment. Adv Exp Med Biol. 2020;1272:17–38.
   PubMed Web of Science ®Google Scholar
• Bozoky B, Savchenko A, Guven H, et al. Decreased decorin expression in the tumor microenvironment. Cancer Med. 2014;3(3):485–491.
   PubMed Web of Science ®Google Scholar
• Shi X, Liang W, Yang W, et al. Decorin is responsible for progression of non-small-cell lung cancer by promoting cell proliferation and metastasis. Tumour Biol. 2015;36(5):3345–3354.
   PubMedGoogle Scholar
• Neill T, Schaefer L, Iozzo RV. Decorin as a multivalent therapeutic agent against cancer. Adv Drug Deliv Rev. 2016;97:174–185.
   PubMed Web of Science ®Google Scholar
• Kong QF, Lv B, Wang B, et al. Association of von Willebrand factor (vWF) expression with lymph node metastasis and hemodynamics in papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(5):2564–2571.
   PubMed Web of Science ®Google Scholar
• Mojiri A, Stoletov K, Carrillo MAL, et al. Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin. Oncotarget. 2017;8(8):13015–13029.
   PubMedGoogle Scholar
• Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003;4(12):915–925.
   PubMed Web of Science ®Google Scholar
• Mazzone M, Comoglio PM. The met pathway: master switch and drug target in cancer progression. FASEB J. 2006;20(10):1611–1621.
   PubMed Web of Science ®Google Scholar
• Nair RM, Prabhu V, Manukonda R, et al. Overexpression of metastasis-associated in colon cancer 1 in retinoblastoma. Tumor Biol. 2020;42.
   Google Scholar
• Tong G, Cheng B, Li J, et al. MACC1 regulates PDL1 expression and tumor immunity through the c-Met/AKT/mTOR pathway in gastric cancer cells. Cancer Med. 2019;8(16):7044–7054.
   PubMed Web of Science ®Google Scholar
• Wu Z, Lin Y. Long noncoding RNA LINC00515 promotes cell proliferation and inhibits apoptosis by sponging miR-16 and activating PRMT5 expression in human glioma. Onco Targets Ther. 2019;12:2595–2604.
   PubMed Web of Science ®Google Scholar
• Lu D, Yang C, Zhang Z, et al. Knockdown of Linc00515 inhibits multiple myeloma autophagy and chemoresistance by upregulating miR-140-5p and downregulating ATG14. Cell Physiol Biochem. 2018;48(6):2517–2527.
   PubMedGoogle Scholar
• Rollins-Raval M, Pillai R, Warita K, et al. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations. Appl Immunohistochem Mol Morphol. 2013;21(3):212–217.
   PubMedGoogle Scholar
• Jiang G, Atenafu EG, Capo-Chichi JM, et al. Prognostic relevance of CD123 expression in adult AML with normal karyotype. Br J Haematol. 2020;188(1):181–184.
   PubMed Web of Science ®Google Scholar
• Arai N, Homma M, Abe M, et al. Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia. Int J Hematol. 2019;109(5):539–544.
   PubMed Web of Science ®Google Scholar
• Jeha S, Smith FO, Estey E, et al. Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels. Leuk Res. 2002;26(4):399–402.
   PubMed Web of Science ®Google Scholar
• Bolouri H, Farrar JE, Triche T, et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018;24(1):103–112.
   PubMed Web of Science ®Google Scholar
• Bullinger L, Döhner K, Kranz R, et al. An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML. Blood. 2008;111(9):4490–4495.
   PubMed Web of Science ®Google Scholar
• Tibshirani R, Hastie T, Narasimhan B, et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A. 2002;99(10):6567–6572.
   PubMed Web of Science ®Google Scholar
• Zhu R, Tao H, Lin W, et al. Identification of an immune-related gene signature based on immunogenomic landscape analysis to predict the prognosis of adult acute myeloid leukemia patients. Front Oncol. 2020;10:1.
   PubMed Web of Science ®Google Scholar
• Fu Y, Xu M, Cui Z, et al. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia. EBioMedicine. 2020;52:102664.
   PubMed Web of Science ®Google Scholar
• Huang W, Qian T, Cheng Z, et al. Prognostic significance of spinster homolog gene family in acute myeloid leukemia. J Cancer. 2020;11(15):4581–4588.
   PubMed Web of Science ®Google Scholar
• Ohtsu N, Nakatani Y, Yamashita D, et al. Eva1 maintains the stem-like character of glioblastoma-initiating cells by activating the noncanonical NF-κB signaling pathway. Cancer Res. 2016;76(1):171–181.
   PubMed Web of Science ®Google Scholar
• Yu P, Lan H, Song X, et al. High expression of the SH3TC2-DT/SH3TC2 gene pair associated with FLT3 mutation and poor survival in acute myeloid leukemia: an integrated TCGA analysis. Front Oncol. 2020;10:1–15.
   PubMed Web of Science ®Google Scholar
• Ni QZ, Chen Z, Zheng Q, et al. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway. Cancer Sci. 2020;111(5):1500–1513.
   PubMed Web of Science ®Google Scholar